BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33360358)

  • 21. Radiotherapy after surgery for benign cerebral meningioma.
    Soyuer S; Chang EL; Selek U; Shi W; Maor MH; DeMonte F
    Radiother Oncol; 2004 Apr; 71(1):85-90. PubMed ID: 15066300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients.
    Brokinkel B; Holling M; Spille DC; Heß K; Sauerland C; Bleimüller C; Paulus W; Wölfer J; Stummer W
    J Neurosurg; 2017 Apr; 126(4):1201-1211. PubMed ID: 27257838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.
    Champeaux C; Wilson E; Shieff C; Khan AA; Thorne L
    J Neurooncol; 2016 Sep; 129(2):337-45. PubMed ID: 27311726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression-Free Survival and Factors Associated with Postoperative Recurrence in 126 Patients with Atypical Intracranial Meningioma.
    Phonwijit L; Khawprapa C; Sitthinamsuwan B
    World Neurosurg; 2017 Nov; 107():698-705. PubMed ID: 28838877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up after surgical removal of meningioma of the inner third of the sphenoidal wing: outcome determinants and different strategies.
    Talacchi A; Hasanbelliu A; D'Amico A; Regge Gianas N; Locatelli F; Pasqualin A; Longhi M; Nicolato A
    Neurosurg Rev; 2020 Feb; 43(1):109-117. PubMed ID: 30187296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Outcome After Spinal Meningioma Surgery. A Nationwide Population-Based Study.
    Champeaux-Depond C; Penet N; Weller J; Huec JL; Jecko V
    Neurospine; 2022 Mar; 19(1):96-107. PubMed ID: 35378584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome comparison between younger and older patients undergoing intracranial meningioma resections.
    Poon MT; Fung LH; Pu JK; Leung GK
    J Neurooncol; 2013 Sep; 114(2):219-27. PubMed ID: 23737294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign meningiomas: primary treatment selection affects survival.
    Condra KS; Buatti JM; Mendenhall WM; Friedman WA; Marcus RB; Rhoton AL
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):427-36. PubMed ID: 9308947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
    Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
    World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant Meningioma: An International Multicentre Retrospective Study.
    Champeaux C; Jecko V; Houston D; Thorne L; Dunn L; Fersht N; Khan AA; Resche-Rigon M
    Neurosurgery; 2019 Sep; 85(3):E461-E469. PubMed ID: 30566646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
    Gallagher MJ; Jenkinson MD; Brodbelt AR; Mills SJ; Chavredakis E
    Clin Neurol Neurosurg; 2016 Feb; 141():117-21. PubMed ID: 26780494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningiomas engaging major venous sinuses.
    Mathiesen T; Pettersson-Segerlind J; Kihlström L; Ulfarsson E
    World Neurosurg; 2014 Jan; 81(1):116-24. PubMed ID: 23376533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survival.
    Champeaux C; Houston D; Dunn L; Resche-Rigon M
    Acta Neurochir (Wien); 2019 Nov; ():. PubMed ID: 31707459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and histopathological predictors of outcome in malignant meningioma.
    Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
    Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma Knife radiosurgery for posterior fossa meningiomas: a multicenter study.
    Sheehan JP; Starke RM; Kano H; Barnett GH; Mathieu D; Chiang V; Yu JB; Hess J; McBride HL; Honea N; Nakaji P; Lee JY; Rahmathulla G; Evanoff WA; Alonso-Basanta M; Lunsford LD
    J Neurosurg; 2015 Jun; 122(6):1479-89. PubMed ID: 25859812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma Knife surgery for convexity, parasagittal, and falcine meningiomas.
    Hasegawa T; Kida Y; Yoshimoto M; Iizuka H; Ishii D; Yoshida K
    J Neurosurg; 2011 May; 114(5):1392-8. PubMed ID: 21128736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
    Champeaux C; Dunn L
    World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma Knife surgery of meningiomas located in the posterior fossa: factors predictive of outcome and remission.
    Starke RM; Nguyen JH; Rainey J; Williams BJ; Sherman JH; Savage J; Yen CP; Sheehan JP
    J Neurosurg; 2011 May; 114(5):1399-409. PubMed ID: 21214335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of linear accelerator-based radiosurgery for intracranial meningiomas.
    Hakim R; Alexander E; Loeffler JS; Shrieve DC; Wen P; Fallon MP; Stieg PE; Black PM
    Neurosurgery; 1998 Mar; 42(3):446-53; discussion 453-4. PubMed ID: 9526976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of parasagittal and falx meningiomas.
    Nowak A; Marchel A
    Neurol Neurochir Pol; 2007; 41(4):306-14. PubMed ID: 17874338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.